HIV-1 and the hijacking of dendritic cells: a tug of war.
2005 (English)In: Springer Seminars in Immunopathology, ISSN 0344-4325, E-ISSN 1432-2196, Vol. 26, no 3, 309-328 p.Article in journal (Refereed) Published
Dendritic cells are critical for host immunity and are involved both in the innate and adaptive immune responses. They are among the first cells targeted by HIV-1 in vivo at mucosal sites. Dendritic cells can sequester HIV-1 in endosomal compartments for several days and transmit infectious HIV-1 to interacting T cells in the lymph node, which is the most important site for viral replication and spread. Initially, the cellular immune response developed against HIV-1 is strong, but eventually it fails to control and resolve the infection. The most dramatic effect seen on the immune system during untreated HIV-1 infection is the destruction of helper CD4+ T cells, which leads to subsequent immune deficiency. However, the immunomodulatory effects of HIV-1 on different dendritic cell subpopulations may also play an important role in the pathogenesis of HIV-1. This review discusses the effects HIV-1 exerts on dendritic cells in vivo and in vitro, including the binding and uptake of HIV by dendritic cells, the formation of infectious synapses, infection, and the role of dendritic cells in HIV-1 pathogenesis.
Place, publisher, year, edition, pages
2005. Vol. 26, no 3, 309-328 p.
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-36522DOI: 10.1007/s00281-004-0178-yLocal ID: 31508OAI: oai:DiVA.org:liu-36522DiVA: diva2:257370